Detalles de la búsqueda
1.
A multi-herb-combined remedy to overcome hyper-inflammatory response by reprogramming transcription factor profile and shaping monocyte subsets.
Pharmacol Res;
169: 105617, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33872811
2.
Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models.
STAR Protoc;
4(1): 102049, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36861832
3.
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.
Nat Cancer;
3(5): 629-648, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422502
4.
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma.
EBioMedicine;
71: 103571, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34530385
5.
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma.
Front Immunol;
12: 637146, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34025646
6.
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas.
Cancer Res;
79(16): 4026-4041, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31201162
7.
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.
Nat Cancer;
3(7): 899, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35739422
8.
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma.
J Clin Invest;
131(16)2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34228644
Resultados
1 -
8
de 8
1
Próxima >
>>